In vitro sensitivity of Mycobacterium xenopi to five antibiotics

Pathologie Biologie

Volumn 50, Issue 10, 2002, Pages 591-594

  Dauendorffer, J N ^a   Laurain, C ^a   Weber, M ^a   Dailloux, M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Antibiotics; Mycobacterium xenopi

Indexed keywords

AMIKACIN; CLARITHROMYCIN; ETHAMBUTOL; OFLOXACIN; RIFAMPICIN;

AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DRUG PENETRATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM XENOPEI; NONHUMAN;

AMIKACIN; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; ETHAMBUTOL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM XENOPI; OFLOXACIN; RIFAMPIN;

EID: 0036919640     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00360-7     Document Type: Article

References (19)

1. Inderlied CB, Salfinger M. Antimycobacterial agents and susceptibility tests. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th Ed. Washington DC: ASM; 1999. p. 1601-23.
2. Terashima T, Sakamaki F, Hasegawa N, Kanazawa M, Kawashiro T. Pulmonary infection due to Mycobacterium xenopi. Int Med 1994; 33:536-9.
3. Anonymous. Diagnosis and treatment of diseases caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156(Suppl.): S1-25.
4. Garcia-Rodriguez JA, Gomez Garcia AC. In vitro activities of quinolones against mycobacteria. J Antimicrobial Chemother 1993; 32:797-808.
5. Telles MAS, Yates MD. Single and double drug susceptibility testing of Mycobacterium avium complex and mycobacteria other than the tubercle (MOTT) bacilli by a microdilution broth minimum inhibitory concentration (MIC) method. Tubercle and Lung Disease 1994;75:286-90.
6. Maugein J, Fourche J, Mormede M, Pellegrin JL. Sensibilité in vitro de Mycobacterium avium et Mycobacterium xenopi à l'érythromycine, roxithromycine et doxycycline. Pathol Biol 1989; 37:565-7.
7. Inderlied CB, Nash KA. Antimycobacterial agents: In vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biological fluids. Antibiotics in Laboratory Medicine. 4th Ed. Baltimore: Williams and Wilkins Co; 1996. p. 127-75.
8. Frashini F, Scaglione F, Pintucci G, Maccarinelli G, Dugnani S, Demartini G. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrobial Chemother 1991;27:61-5.
9. Berlin OGW, Young LS, Floyd-Reising SA, Bruckner DA. Comparative in vitro activity of the new macrolide A56268 against Mycobacteria. Eur J Clin Microbiol 1987;6:486-7.
10. Watt B. In-vitro sensitivities and treatment of less common mycobacteria. J Antimicrobial Chemother 1997;39:567-74.
11. Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Kallenius G. In vitro synergistic activity between etambutol and fluorinated quinolones against Mycobacterium avium complex. J Antimicrobial Chemother 1989;24:317-24.
12. Kallenius G, Svenson SB, Hoffner SE. Ethambutol: A key for Mycobacterium avium complex chemotherapy. Am Revue Respir Dis 1989;140:264.
13. Hoffner SE, Svenson SB, Beezer AE. Microcalorimetric studies of the initial interaction between antimycobacterial drugs and Mycobacterium avium. J Antimicrobial Chemother 1990;25:353-9.
14. Couraud L, Fourtillan JB, Saux MC, Bryskier A, Vincent du Laurier M. Diffusion of ofloxacin into human lung tissue. Drugs 1987;34:37-8.
15. Rastogi N, Goth KS, David HL. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and Mycobacterium xenopi. Ann Inst Pasteur Microbiol 1988;139:233-7.
16. Truffot-Pernot C, Grosset J. Activities of pefloxacin and ofloxacin against mycobacteria: In vitro and mouse experiments. Tubercle 1991;72:57-64.
17. Young LS, Berlin OGW. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. The Am J Med 1987;82: 23-6.
18. Truffot-Pernot C, Giroir AM, Maury L, Grosset J. Etude des concentrations minima inhibitrices de rifabutine (Ansamycine LM427) pour Mycobacterium xenopi et Mycobacterium aviumintracellulare. Revue des Maladies Respiratoires 1988;5:401-6.
19. Kenny MT, Strates B. Metabolism and pharmamokinetics of the antibiotic rifampin. 12. Drug and Metabolism Revue 1981;12: 159-218.